Sintx Technologies (SINT) Cash from Operations Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Sintx Technologies | 8.71 Mn | 6.82 Mn | 144,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.58% |
| Dec 31, 2025 | -2.66% |
| Sep 30, 2025 | -3.51% |
| Jun 30, 2025 | -9.37% |
| Mar 31, 2025 | 17.48% |
| Dec 31, 2024 | 6.30% |
| Sep 30, 2024 | -10.70% |
| Jun 30, 2024 | -6.27% |
| Mar 31, 2024 | -9.97% |
| Dec 31, 2023 | -14.22% |
| Sep 30, 2023 | -10.08% |
| Jun 30, 2023 | 2.71% |
| Mar 31, 2023 | -16.37% |
| Dec 31, 2022 | -39.40% |
| Sep 30, 2022 | -5.66% |
| Jun 30, 2022 | -9.74% |
| Mar 31, 2022 | -11.65% |
| Dec 31, 2021 | -4.23% |
| Sep 30, 2021 | 3.19% |
| Jun 30, 2021 | -20.35% |
| Mar 31, 2021 | -15.35% |
| Dec 31, 2020 | -0.57% |
| Sep 30, 2020 | -3.99% |
| Jun 30, 2020 | 8.12% |
| Mar 31, 2020 | -2.72% |
| Dec 31, 2019 | 12.82% |
| Sep 30, 2019 | 12.58% |
| Jun 30, 2019 | 23.90% |
| Mar 31, 2019 | 3.22% |
| Dec 31, 2018 | 18.53% |
| Sep 30, 2018 | 0.13% |
| Jun 30, 2018 | -7.40% |
| Mar 31, 2018 | -15.54% |